Drugs Made In America Acquisition II Corp. (DMII)

Market Cap	649.10M +1.9%
Revenue (ttm)	n/a
Net Income	13.02M
EPS	0.24
Shares Out	63.70M
PE Ratio	41.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Open	10.19
Previous Close	10.19
Day's Range	10.19 - 10.19
52-Week Range	9.86 - 10.33
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DMII

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

• Industry: Shell Companies
• Sector: Financials
• IPO Date: Sep 25, 2025
• Country: United States
• Stock Exchange: Nasdaq
• Ticker Symbol: DMII

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 16, 2026

Data Sources Report a data error